Vitamin D3 for Life

Live Enlightened

Physiology

Childhood Vitamin D, Immune Development and Neurodevelopment: Study Summary

Previous related pageChildhood Vitamin D, Immune Development and Neurodevelopment: Full Evidence ReviewNext related pageChildhood Vitamin D, Immune Development and Neurodevelopment: Full Evidence Review
Study at a glance

What was studied?

What do childhood vitamin D studies show about immune and nervous-system development?

What did the studies find?

Four childhood study populations measured immune markers, thinking tasks or school results. Some immune markers changed, but the studies did not establish better immune maturation or a general cognitive benefit. They did not directly measure vitamin D signalling inside nerve cells.

What does this mean?

A laboratory change does not necessarily mean better protection against illness. A thinking test cannot by itself explain a cellular mechanism. These studies leave important developmental questions unanswered.

What are the limits?

Some trials were short or small, and observational studies could not remove every family or social difference. Evidence was limited for severe deficiency. Additional reports were unavailable in full. The findings do not prove that vitamin D has no physiological role or establish a personal blood target.

Read the full article below ↓

Studies of vitamin D in childhood measure different things: blood status, immune cells, thinking tasks and school results. These measurements do not all show how an immune system or nervous system develops. Four childhood study populations provide useful evidence, but they do not establish a general developmental benefit from higher vitamin D status or directly measure vitamin D signalling inside neurons. For the detailed evidence review, read Childhood Vitamin D, Immune Development and Neurodevelopment: Full Evidence Review.

For current UK guidance, including advice for children, see the NHS page Vitamin D.

Blood status is not a direct measure of development

The usual blood measurement is 25-hydroxyvitamin D, written as 25(OH)D. It indicates circulating vitamin D status. It does not directly show how an immune cell or nerve cell responds to the active vitamin D hormone.

An immune-cell change may be real without making a child less likely to become ill. Vitamin D and Immunity introduces the broader immune question. Similarly, a thinking task or school exam can measure performance without explaining a cellular mechanism. Keeping these outcomes separate helps prevent stronger conclusions than the studies support. How to Read Vitamin D Evidence Across Brain Models explains the difference between laboratory models and human outcomes.

Two trials examined immune or cognitive outcomes

A Montreal investigation included a survey of 457 young children and an analysis of a 12-week food-fortification trial involving 77 children. In the trial, fortified foods increased vitamin D status. The investigators found some immune differences, including a higher percentage of lymphocytes, a type of white blood cell, in one group.

They also stimulated cells in the laboratory. This was a laboratory test using a stimulating substance, not a bacterial infection. Release of one immune signalling molecule, interleukin-6, was lower in the fortified groups. Other measured responses did not show a consistent advantage, and reported illness outcomes were not different.

These findings do not prove that the children’s immune systems matured faster or protected them better. From Cellular Cytokine Responses to Systemic Inflammation explains why a changed cell response need not mean a clinical benefit. The immune analyses involved small groups, and the trial was short. Some measurements varied widely. The survey also linked higher status with higher inflammatory markers, but this association cannot establish that vitamin D caused inflammation or harm.

A Northern Irish trial assigned 118 children aged four to 11 to vitamin D spray or placebo for 12 weeks. The main report described 102 completers, with missing endpoint measurements handled using baseline values. Blood status increased, but the study did not establish a cognitive or immune advantage after accounting for the many comparisons made.

These outcomes were exploratory. The trial was mainly designed around blood status, and many participants were siblings. Family similarities, uneven missing data and small immune groups limit confidence in the developmental findings. A suggested trend in a thinking task should not be described as a proven benefit.

Two cohorts followed children over time

The British ALSPAC study measured substances formed as the body processes vitamin D at an average age of about ten and examined later school results in 3,171 children with the required data. It did not find a clear association between vitamin D3 status and academic performance after adjustment. A weak inverse association involving vitamin D2 does not establish that vitamin D2 harms learning.

This was an observational study. Children were not assigned to different vitamin D levels. Family circumstances can affect both blood measurements and school results, and statistical adjustment cannot remove every possible difference. The analysed families were relatively advantaged, and one blood sample could not describe status throughout childhood.

A Ugandan study measured status in 302 children between one and four years and tested cognitive and motor skills at five. It did not find an adjusted association with these outcomes. However, only eight children had status below 50 nanomoles per litre (nmol/L), a unit for blood concentration, so it offered little evidence about markedly low status. The selected follow-up sample and unmeasured family influences also limit interpretation.

Does treatment during infancy answer the same question?

A Finnish trial compared two vitamin D amounts during infancy and later assessed children at six to eight years. It did not demonstrate a neurocognitive advantage from the higher infant dose. However, this is evidence about infant exposure followed by school-age testing. It does not test starting supplementation during childhood, and its follow-up reports are not separate independent trials.

What remains uncertain?

The directly assessed studies do not demonstrate better immune maturation or a general cognitive advantage from higher status. They also do not directly test vitamin D signalling inside developing neurons. That measurement gap does not mean vitamin D has no physiological role.

Some additional immune and cognition reports were unavailable in full. One positive cognition report involved several nutrients, so its result cannot be attributed to vitamin D alone. The assessment is therefore not a claim that every study agrees.

Evidence remains limited for severe deficiency, long-term clinical immune development and direct neuronal mechanisms. Research supplement schedules are not personal instructions, and these studies do not establish a universal blood target for a child’s development.

Scientific sources

Not reportedVitamin D Status and Immune Health Outcomes in a Cross-Sectional Study and a Randomized Trial of Healthy Young Children. Brett NR et al. Nutrients. 2018;10:680. DOI:10.3390/nu10060680.

Not reportedThe Effect of Vitamin D3 Supplementation on Vitamin D Status and Associated Health Outcomes in Children: A Randomized Controlled Trial. Royle E et al. Journal of Nutrition. 2026;156:101493. DOI:10.1016/j.tjnut.2026.101493.

Not reportedAssociation of serum 25-hydroxyvitamin D3 and D2 with academic performance in childhood: findings from a prospective birth cohort. Tolppanen AM et al. Journal of Epidemiology and Community Health. 2012;66:1137 to 1142. DOI:10.1136/jech-2011-200114.

Not reportedVitamin D Status Is Not Associated with Cognitive or Motor Function in Pre-School Ugandan Children. Mutua AM et al. Nutrients. 2020;12:1662. DOI:10.3390/nu12061662.

Not reportedEarly life vitamin D and neurocognitive abilities at age 6 to 8 years: a randomized clinical trial and observational analysis. Seppälä V et al. European Child & Adolescent Psychiatry. 2026;35:587 to 597. DOI:10.1007/s00787-025-02891-7.

Not reportedWinter cholecalciferol supplementation at 55°N has little effect on markers of innate immune defense in healthy children aged 4 to 8 years: a secondary analysis from a randomized controlled trial. Hauger H et al. European Journal of Nutrition. 2019;58:1453 to 1462. Abstract-level access; not counted as fully assessed.

Not reportedEffects of fortified milk on cognitive abilities in school-aged children: results from a randomized-controlled trial. Petrova D et al. European Journal of Nutrition. 2019;58:1863 to 1872. Identifiable institutional publication record; complete paper not assessed. Multinutrient intervention, not an isolated vitamin D test.

Related reading

Original sources

Source

Vitamin D

For current UK guidance, including advice for children, see the NHS page Vitamin D.

Publication details

For current UK guidance, including advice for children, see the NHS page Vitamin D.

Read more →
Source

Association of serum 25-hydroxyvitamin D3 and D2 with academic performance in childhood: findings from a prospective birth cohort

Published in Tolppanen AM et al. Journal of Epidemiology and Community Health (2012).

Publication details

Not reportedAssociation of serum 25-hydroxyvitamin D3 and D2 with academic performance in childhood: findings from a prospective birth cohort. Tolppanen AM et al. Journal of Epidemiology and Community Health. 2012;66:1137 to 1142. DOI:10.1136/jech-2011-200114.

Read more →
Source

Early life vitamin D and neurocognitive abilities at age 6 to 8 years: a randomized clinical trial and observational analysis

Participants were from a Finnish vitamin D double-blind randomized clinical trial and classified themselves white.

Publication details

Not reportedEarly life vitamin D and neurocognitive abilities at age 6 to 8 years: a randomized clinical trial and observational analysis. Seppälä V et al. European Child & Adolescent Psychiatry. 2026;35:587 to 597. DOI:10.1007/s00787-025-02891-7.

Read more →
Source

Winter cholecalciferol supplementation at 55°N has little effect on markers of innate immune defense in healthy children aged 4–8 years: a secondary analysis from a randomized controlled trial

Published in Hauger H et al. European Journal of Nutrition (2019).

Publication details

Not reportedWinter cholecalciferol supplementation at 55°N has little effect on markers of innate immune defense in healthy children aged 4 to 8 years: a secondary analysis from a randomized controlled trial. Hauger H et al. European Journal of Nutrition. 2019;58:1453 to 1462. Abstract-level access; not counted as fully assessed.

Read more →
Source

Effects of fortified milk on cognitive abilities in school-aged children: results from a randomized-controlled trial

Published in Petrova D et al. European Journal of Nutrition (2019).

Publication details

Not reportedEffects of fortified milk on cognitive abilities in school-aged children: results from a randomized-controlled trial. Petrova D et al. European Journal of Nutrition. 2019;58:1863 to 1872. Identifiable institutional publication record; complete paper not assessed. Multinutrient intervention, not an isolated vitamin D test.

Read more →